GlassScriptPhysician profile
Antonise Johnson
NPI 1326517731
$4,785.32
in general payments reported to CMS, 2019-2025
9 companies · $661 in 2025
The $661 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,500 · 2023: $287 · 2024: $338 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,606.79 | 2021-2025 | |
| Abbvie INC. | $671.34 | 2023-2025 | |
| Viiv Healthcare Company | $153.30 | 2025 | Cabenuva |
| Alkermes, INC. | $130.45 | 2024-2025 | Vivitrol |
| Teva Pharmaceuticals USA, INC. | $115.75 | 2025 | Austedo Xr |
| Exact Sciences Corporation | $51.32 | 2023-2025 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $23.76 | 2024 | Ingrezza |
| Paratek Pharmaceuticals, INC. | $17.96 | 2023 | Nuzyra |
| Organon LLC | $14.65 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonise Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.